Oxaliplatin in Esophagus Cancer (Advanced) 1st Line

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 29, 2000

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions

Esophageal Neoplasms

Interventions

DRUG

Oxaliplatin + cisplatin + 5-Fluorouracil (5-FU)

OXALIPLATIN 60 mg/m2/d, CISPLATIN 55 mg/m2/d, 5-FU 600 mg/m2/d with dose range and followed by radiotherapy

Trial Locations (1)

Sanofi-Aventis Administrative Office, Barcelona